Nuvectis Pharma, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Nuvectis Pharma, Inc. (NVCT) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 9.16 million shares for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-05-12
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 9.16M shares, a 134.85% increase year-over-year.
- Nuvectis Pharma, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 3.90M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month |
|---|---|
| 2022-03-31 | 9.16M shares 10-Q · filed 2022-05-12 |
| 2021-03-31 | 3.90M shares 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |